Structures by: Low J. N.
Total: 892
N-isonicotinoyl benzaldehydehydrazone
C13H11N3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.1927(2)Å b=21.2168(7)Å c=28.6771(10)Å
α=90.00° β=90.00° γ=90.00°
N-isonicotinoyl 2-fluorobenzaldehydehydrazone
C13H10FN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.4815(2)Å b=11.1344(2)Å c=14.5365(3)Å
α=90.663(2)° β=104.903(3)° γ=109.268(2)°
N-isonicotinoyl 4-fluorobenzaldehydehydrazone monohydrate
C13H10FN3O,H2O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=6.4189(3)Å b=6.8520(3)Å c=27.3451(12)Å
α=90.00° β=90.00° γ=90.00°
N-isonicotinoyl 2-chlorobenzaldehydehydrazone
C13H10ClN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.9977(2)Å b=6.7184(2)Å c=22.5514(6)Å
α=90.00° β=98.609(3)° γ=90.00°
N-isonicotinoyl 3-chlorobenzaldehydehydrazone
C13H10ClN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.4524(3)Å b=11.2367(4)Å c=14.3949(3)Å
α=90.00° β=102.701(2)° γ=90.00°
N-isonicotinoyl 3-bromobenzaldehydehydrazone
C13H10BrN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.4578(2)Å b=11.3264(3)Å c=14.3558(3)Å
α=90.00° β=101.119(2)° γ=90.00°
N-isonicotinoyl 2-bromobenzaldehydehydrazone
C13H10BrN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=8.0268(2)Å b=6.7134(3)Å c=22.5024(10)Å
α=90.00° β=99.297(3)° γ=90.00°
N-isonicotinoyl 3-methoxybenzaldehydehydrazone
C14H13N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=8.2938(4)Å b=11.0771(6)Å c=13.846(5)Å
α=90.00° β=103.478(3)° γ=90.00°
N-isonicotinoyl 4-bromobenzaldehydehydrazone
C13H10BrN3O,H2O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=14.2570(3)Å b=14.6299(4)Å c=14.1669(4)Å
α=90.00° β=119.152(2)° γ=90.00°
N-isonicotinoyl 2-methoxybenzaldehydehydrazone
C14H13N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=9.8899(3)Å b=15.8189(4)Å c=17.0380(5)Å
α=90.00° β=97.236(2)° γ=90.00°
N-isonicotinoyl 4-methoxybenzaldehydehydrazone
C14H13N3O2,H2O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.2702(2)Å b=12.3085(5)Å c=14.7299(6)Å
α=90.00° β=97.370(3)° γ=90.00°
N-isonicotinoyl 2-ethoxybenzaldehydehydrazone
C15H15N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=8.3787(3)Å b=18.2450(7)Å c=17.8701(7)Å
α=90.00° β=90.975(2)° γ=90.00°
N-isonicotinoyl 3-ethoxybenzaldehydehydrazone
C15H15N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=24.2060(17)Å b=5.5637(4)Å c=9.9571(4)Å
α=90.00° β=94.965(4)° γ=90.00°
N-isonicotinoyl 3-fluorobenzaldehydehydrazone
C13H10FN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=13.1910(4)Å b=18.8057(6)Å c=18.2843(4)Å
α=90.00° β=90.00° γ=90.00°
Triaqua-bis[N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4- oxopyrimidin-2-yl)glycinato]disodium
C7H11N5NaO5.5
Acta Crystallographica Section B (2001) 57, 3 317-328
a=7.57020(10)Å b=11.5237(2)Å c=13.3743(3)Å
α=104.4350(8)° β=97.8415(8)° γ=103.5004(7)°
Triaqua-N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidine-2-yl) glycinatolithium,
C7H14LiN5O7
Acta Crystallographica Section B (2001) 57, 3 317-328
a=24.7736(6)Å b=7.6525(3)Å c=14.0096(5)Å
α=90.00° β=114.3751(13)° γ=90.00°
Aqua-N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4- oxopyrimidin-2-yl)glycinatopotassium
C7H10KN5O5
Acta Crystallographica Section B (2001) 57, 3 317-328
a=7.8114(2)Å b=16.4811(5)Å c=8.5560(2)Å
α=90.00° β=100.408(2)° γ=90.00°
Tetraaqua-bis[N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4- oxopyrimidin-2-yl)glycinato]manganese(II) hexahydrate
C14H24MnN10O12,6(H2O)
Acta Crystallographica Section B (2001) 57, 3 317-328
a=7.4476(3)Å b=8.2351(4)Å c=12.6372(5)Å
α=105.258(2)° β=92.153(3)° γ=108.94(2)°
N-phenylpyrazinecarboxamide
C11H9N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9716(3)Å b=7.5270(4)Å c=11.0318(6)Å
α=83.295(3)° β=85.377(4)° γ=69.009(3)°
N-(2-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=15.5361(9)Å b=7.0360(3)Å c=18.9863(9)Å
α=90.00° β=91.307(2)° γ=90.00°
N-(3-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=10.2736(4)Å b=10.8639(4)Å c=18.5040(5)Å
α=90.00° β=90.1970(19)° γ=90.00°
N-(2-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.6748(3)Å b=7.8967(3)Å c=9.8421(5)Å
α=96.682(2)° β=103.357(3)° γ=101.659(2)°
N-(4-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8885(6)Å b=7.5257(9)Å c=13.2762(16)Å
α=78.349(7)° β=86.460(8)° γ=70.146(8)°
N-(4-fluorophenyl)pyrazinecarboxamide, P2~1~/c polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=11.718(2)Å b=5.9726(10)Å c=13.474(2)Å
α=90.00° β=91.446(9)° γ=90.00°
N-(3-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.9121(3)Å b=10.9457(3)Å c=18.6827(4)Å
α=90.00° β=92.026(2)° γ=90.00°
N-(4-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8636(3)Å b=7.2433(5)Å c=13.1459(9)Å
α=100.854(3)° β=97.750(4)° γ=110.783(4)°
N-(4-fluorophenyl)pyrazinecarboxamide, Pc polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9666(3)Å b=24.2205(15)Å c=13.0262(7)Å
α=90.00° β=91.720(3)° γ=90.00°
N-(2-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2
Acta Crystallographica Section B (2008) 64, 1 84-100
a=14.1667(4)Å b=20.7513(6)Å c=7.4516(3)Å
α=90.00° β=90.00° γ=90.00°
N-(3-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2,H2O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.9386(2)Å b=8.5820(3)Å c=19.0670(6)Å
α=90.00° β=99.394(2)° γ=90.00°
N-(2-nitrophenyl)pyrazinecarboxamide?
C11H8N4O3
Acta Crystallographica Section B (2008) 64, 1 84-100
a=3.6598(2)Å b=21.7123(17)Å c=13.1158(10)Å
α=90.00° β=91.281(5)° γ=90.00°
N-(2,6-difluorophenyl)pyrazinecarboxamide
C11H7F2N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.8054(4)Å b=10.9355(5)Å c=19.4805(9)Å
α=90.00° β=103.474(2)° γ=90.00°
N-(2,6-dimethylphenyl)pyrazinecarboxamide
C13H13N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.3977(4)Å b=10.7671(5)Å c=15.2457(4)Å
α=90.00° β=101.665(3)° γ=90.00°
N-(2-chloro-4-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=18.733(4)Å b=3.8502(8)Å c=14.839(3)Å
α=90.00° β=99.472(3)° γ=90.00°
N-(4-chloro-2-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.8885(2)Å b=10.5369(5)Å c=14.6683(7)Å
α=90.00° β=99.008(3)° γ=90.00°
8-methyl-7-(4-chlorophenyl)-10-phenyl-6,10-dihydro- 5H-benzo[h]pyrazolo[3,4-b]quinoline
C27H20ClN3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=12.1072(4)Å b=14.2672(5)Å c=12.7635(4)Å
α=90.00° β=109.953(8)° γ=90.00°
8-methyl-7-(3-pyridinyl)-10-phenyl-6,10- dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C26H20N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.2274(6)Å b=13.7079(8)Å c=12.6935(7)Å
α=90.00° β=95.731(3)° γ=90.00°
11-(3,4,5-trimethoxyphenyl)-10-methyl-8-phenyl-6,8- dihydro-5H-benzo[f]pyrazolo[3,4-b]quinoline
C30H27N3O3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=10.4716(9)Å b=20.0027(18)Å c=12.1529(9)Å
α=90.00° β=107.818(4)° γ=90.00°
8-methyl-7-(4-pyridinyl)-10-phenyl-10H- benzo[h]pyrazolo[3,4-b]quinoline
C26H18N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.3560(3)Å b=17.3507(5)Å c=9.7577(2)Å
α=90.00° β=97.262(2)° γ=90.00°
11-(4-methoxyphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3O
Acta Crystallographica Section B (2008) 64, 1 72-83
a=18.0854(3)Å b=21.2296(5)Å c=23.8007(5)Å
α=90.00° β=108.2580(10)° γ=90.00°
11-(4-methylphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.1334(3)Å b=11.4672(2)Å c=17.6270(4)Å
α=97.858(2)° β=106.135(3)° γ=97.496(2)°
2-Amino-6-benzyloxy-4-(N-methylamino)-5-nitrosopyrimidine
C12H13N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.1122(2)Å b=7.3873(2)Å c=23.3867(7)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-6-benzyloxy-4-(N-butylamino)-5-nitrosopyrimidine
C15H19N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.6146(2)Å b=13.7686(4)Å c=16.1215(5)Å
α=90.00° β=116.6180(15)° γ=90.00°
2-Amino-6-benzyloxy-4-(N-phenylamino)-5-nitrosopyrimidine
C17H15N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=4.7622(3)Å b=5.8123(4)Å c=13.5635(11)Å
α=79.851(2)° β=87.346(2)° γ=89.692(5)°
2-Amino-6-benzyloxy-4-(N-dodecylamino)-5-nitrosopyrimidine
C23H35N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.3567(4)Å b=7.7784(4)Å c=21.4725(14)Å
α=92.000(2)° β=99.840(2)° γ=108.760(2)°
2-amino-6-benzyloxy-4-(N-cyclohexylamino)-5-nitrosopyrimidine
C17H21N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=8.2656(5)Å b=10.6077(6)Å c=10.6743(7)Å
α=64.841(4)° β=71.021(3)° γ=87.275(5)°
2-Amino-6-benzyloxy-4-piperidino-5-nitrosopyrimidine monohydrate
C16H19N5O2,H2O
Acta Crystallographica Section B (2003) 59, 2 263-276
a=7.2557(4)Å b=11.4692(7)Å c=20.4417(15)Å
α=90.00° β=106.113(3)° γ=90.00°
2-Amino-6-benzyloxy-4-piperidino-pyrimidine
C16H20N4O
Acta Crystallographica Section B (2003) 59, 2 263-276
a=6.5025(2)Å b=11.8006(4)Å c=20.7673(10)Å
α=76.1950(14)° β=82.3623(14)° γ=77.330(4)°
2-Amino-4-(N-butylamino)-6-(3-pyridyl)methoxy-5-nitrosopyrimidine
C14H18N6O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=28.3925(6)Å b=8.1627(3)Å c=15.1540(5)Å
α=90.00° β=121.9700(13)° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, Cc polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=4.8443(2)Å b=22.7344(16)Å c=11.4216(8)Å
α=90.00° β=97.636(4)° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, Pbcn polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=22.2727(3)Å b=8.2207(4)Å c=13.5916(7)Å
α=90.00° β=90.00° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, P2~1~ polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=6.1515(9)Å b=4.7875(5)Å c=20.748(3)Å
α=90.000° β=97.540(7)° γ=90.000°
1-(2-chloronicotinoyl)-2-(3-nitrophenyl)hydrazine
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=9.0691(3)Å b=19.6472(5)Å c=7.4302(3)Å
α=90.00° β=110.424(2)° γ=90.00°
1-(2-chloronicotinoyl)-2-(4-nitrophenyl)hydrazine
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=4.58110(10)Å b=24.8913(13)Å c=11.2782(6)Å
α=90.00° β=94.095(3)° γ=90.00°
2-Iodo-5-nitro-aniline
C6H5IN2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=6.4236(15)Å b=7.4979(18)Å c=8.293(2)Å
α=71.422(4)° β=85.285(4)° γ=86.125(4)°
4-Iodo-2-nitroaniline
C6H5IN2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=26.5541(9)Å b=7.0445(2)Å c=16.4416(5)Å
α=90.00° β=101.1548(16)° γ=90.00°
1-(2-Nitrophenylthio)-2,5-pyrrolidinedione
C10H8N2O4S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=7.918(5)Å b=13.132(5)Å c=10.983(5)Å
α=90.00° β=110.7(3)° γ=90.00°
S-(2-Nitrophenyl)benzenecarbothiolate
C13H9NO3S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=7.51(5)Å b=21.16(5)Å c=7.66(5)Å
α=90.00° β=92.043(10)° γ=90.00°
(E)-1-(4-methyl-2-nitrobenzenethiolato)-2-phenylethene
C15H13NO2S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=21.595(3)Å b=14.518(2)Å c=7.9530(7)Å
α=90.00° β=90.00° γ=90.00°
2-Iodo-N-(4-nitrobenzyl)aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=16.1564(6)Å b=9.3589(3)Å c=8.3326(3)Å
α=90.00° β=96.3330(10)° γ=90.00°
3-Iodo-N-(4-nitrobenzyl))aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=7.0966(2)Å b=12.5908(4)Å c=13.8360(6)Å
α=90.00° β=90.00° γ=90.00°
4-Iodo-N-(3-nitrobenzyl))aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=21.2778(15)Å b=8.1809(5)Å c=7.2793(4)Å
α=90.00° β=94.316(2)° γ=90.00°
2,2,3,3',4,4'-Hexaacetato-6,6'-bis-O-(4-toluenesulfonyl)-α,α'-trehalose
C38H46O21S2
Acta Crystallographica Section B (2004) 60, 4 461-471
a=18.1484(9)Å b=21.1046(9)Å c=23.4224(14)Å
α=90.00° β=90.00° γ=90.00°
2-Iodo-N-(2-nitrobenzyl))aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=8.16850(10)Å b=10.8834(2)Å c=15.4372(2)Å
α=76.9219(9)° β=80.0727(7)° γ=74.2167(7)°
2,2,3,3',4,4'-Hexaacetato-6,6'-bis-O-methylsulfonyl-α,α'-trehalose
C26H38O21S2
Acta Crystallographica Section B (2004) 60, 4 461-471
a=21.3279(8)Å b=8.9299(4)Å c=8.8382(4)Å
α=90.00° β=99.4537(17)° γ=90.00°
6,6-diamino-α,α'-trehalose dihydrate
C12H24N2O9,2(H2O)
Acta Crystallographica Section B (2004) 60, 4 461-471
a=8.6093(2)Å b=8.6093(2)Å c=22.1566(8)Å
α=90.00° β=90.00° γ=90.00°
2,2,3,3',4,4'-Hexaacetato-6,6'-diazido-α,α'-trehalose ethanol solvate
C24H32N6O15,0.35(C2H6O)
Acta Crystallographica Section B (2004) 60, 4 461-471
a=12.2281(4)Å b=15.5803(6)Å c=18.1066(8)Å
α=90.00° β=90.00° γ=90.00°
N^4^-(Cyclohexyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H18N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=11.2407(10)Å b=7.3654(5)Å c=15.8178(12)Å
α=90.00° β=106.005(7)° γ=90.00°
N^4^-(3-Chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C11H9ClN6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=11.1960(8)Å b=8.5040(8)Å c=13.3815(12)Å
α=90.00° β=120.674(5)° γ=90.00°
N^4^-Methyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H12N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=10.6661(12)Å b=7.7279(9)Å c=14.359(2)Å
α=90.00° β=100.071(7)° γ=90.00°
2-[4-(6-Amino-1H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]ethanol
C11H17N7O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.0297(9)Å b=13.859(3)Å c=25.766(6)Å
α=90.00° β=90.00° γ=90.00°
N^4^-(4-Methoxyphenyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
2(C13H14N6O),H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=8.9516(5)Å b=12.0627(7)Å c=12.9053(7)Å
α=91.612(4)° β=92.065(3)° γ=95.259(5)°
C11H15ClN4O
C11H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=5.907(2)Å b=10.398(3)Å c=10.801(2)Å
α=110.86(3)° β=94.19(2)° γ=96.00(3)°
C9H13ClN4O
C9H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=11.328(3)Å b=8.0810(4)Å c=11.3849(12)Å
α=90.00° β=98.709(14)° γ=90.00°
C9H11ClN4O2
C9H11ClN4O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.3540(5)Å b=8.2910(13)Å c=17.276(3)Å
α=90.00° β=97.962(9)° γ=90.00°
C12H17ClN4O
C12H17ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.5722(6)Å b=8.7195(5)Å c=8.7681(7)Å
α=82.598(6)° β=82.701(5)° γ=88.645(5)°
C14H15ClN4O
C14H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.9897(5)Å b=8.0922(4)Å c=11.2786(7)Å
α=91.602(4)° β=107.220(5)° γ=91.776(5)°
C13H13ClN4O
C13H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.1811(12)Å b=8.8325(10)Å c=9.3356(6)Å
α=81.844(9)° β=82.015(10)° γ=73.041(7)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.0568(7)Å b=8.211(2)Å c=10.565(3)Å
α=84.590(16)° β=82.363(14)° γ=78.687(14)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.9938(6)Å b=7.9544(10)Å c=10.7507(14)Å
α=81.191(11)° β=82.469(12)° γ=87.333(10)°
C15H12ClN5O
C15H12ClN5O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.5716(7)Å b=16.6432(18)Å c=10.9450(7)Å
α=90.00° β=93.549(6)° γ=90.00°
C18H15ClN4O
C18H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.5520(11)Å b=11.1012(7)Å c=11.4111(4)Å
α=79.958(5)° β=84.802(9)° γ=77.009(9)°
C11H16ClN5O2
C11H16ClN5O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.2147(6)Å b=8.8563(10)Å c=10.2855(12)Å
α=84.856(10)° β=85.296(10)° γ=79.092(7)°
C10H13ClN4O
C10H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=14.4681(17)Å b=11.1378(17)Å c=7.4534(7)Å
α=90.00° β=116.535(7)° γ=90.00°
N^4^-Methyl-N^4^-(4-phenylmethyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine monohydrate
C13H14N6,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=16.5577(12)Å b=8.6833(3)Å c=18.4640(13)Å
α=90.00° β=90.00° γ=90.00°
N^4^-Ethyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
C13H14N6,0.5(H2O)
Acta Crystallographica Section B (2008) 64, 5 610-622
a=17.642(3)Å b=18.278(3)Å c=8.3034(18)Å
α=90.00° β=103.512(17)° γ=90.00°
4-(3,4-Dimethylanilino)-<i>N</i>-(3,4-dimethylphenyl)quinoline-3-carboxamide
C26H25N3O
Acta Crystallographica Section E (2020) 76, 2 201-207
a=6.2502(3)Å b=15.7915(6)Å c=20.7395(9)Å
α=90° β=90° γ=90°
3-[(4-Nitrobenzylidene)amino]-2(<i>R,S</i>)-(4-nitrophenyl)-5(<i>S</i>)-(propan-2-yl)imidazolidin-4-one
C19H19N5O5
Acta Crystallographica Section E (2019) 75, 11 1774-1782
a=6.93460(10)Å b=8.4380(2)Å c=16.6963(5)Å
α=79.826(2)° β=89.848(2)° γ=80.488(2)°
<i>N</i>-(3-Methoxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C17H13NO4
Acta Crystallographica Section E (2015) 71, 5 547-554
a=9.6903(2)Å b=5.5303(4)Å c=24.9335(18)Å
α=90° β=99.162(5)° γ=90°
<i>N</i>-(2-Nitrophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10N2O5
Acta Crystallographica Section E (2015) 71, 5 547-554
a=14.104(9)Å b=12.692(8)Å c=7.340(5)Å
α=90° β=100.065(13)° γ=90°
<i>N</i>-(4-Methylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C17H13NO3
Acta Crystallographica Section E (2015) 71, 5 547-554
a=6.6106(5)Å b=7.0143(5)Å c=15.3749(11)Å
α=91.444(6)° β=95.238(6)° γ=112.551(8)°
<i>N</i>-(4-Methoxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C17H13NO4
Acta Crystallographica Section E (2015) 71, 5 547-554
a=14.1629(10)Å b=6.772(5)Å c=15.1898(11)Å
α=90° β=116.607(11)° γ=90°
<i>N</i>-(4-Hydroxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H11NO4
Acta Crystallographica Section E (2015) 71, 5 547-554
a=7.0756(5)Å b=12.5125(9)Å c=14.2944(10)Å
α=86.267(8)° β=83.839(8)° γ=84.588(8)°
2-Methoxy-benzaldehyde oxime
C8H9NO2
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=11.1719(2)Å b=16.4260(3)Å c=4.02490(10)Å
α=90° β=90° γ=90°
2,3-Dimethoxy-benzaldehyde oxime
C9H11NO3
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=4.6775(2)Å b=13.0996(5)Å c=14.1984(5)Å
α=90° β=90° γ=90°
2,4-Dimethoxybenzaldehyde oxime
C9H11NO3
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=4.9441(2)Å b=8.2188(4)Å c=12.1308(3)Å
α=108.849(3)° β=92.288(3)° γ=106.273(4)°
2,5-Dimethoxybenzaldehyde oxime
C9H11NO3
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=7.64800(10)Å b=21.3380(4)Å c=10.9421(2)Å
α=90° β=90.555(2)° γ=90°
2-Hydroxy-4-methylbenzaldehyde oxime
C8H9NO2
Acta Crystallographica Section E (2018) 74, 10 1480-1485
a=6.5507(2)Å b=7.2523(2)Å c=15.5478(4)Å
α=90° β=96.737(3)° γ=90°
2,4-Dihydroxybenzaldehyde oxime
C7H7NO3
Acta Crystallographica Section E (2018) 74, 10 1480-1485
a=3.72410(10)Å b=8.6902(2)Å c=20.7570(5)Å
α=90° β=92.501(2)° γ=90°
2-Hydroxy-4-methoxybenzaldehyde oxime
C8H9NO3
Acta Crystallographica Section E (2018) 74, 10 1480-1485
a=9.3591(13)Å b=6.2634(7)Å c=13.6260(2)Å
α=90° β=108.636(16)° γ=90°
(<i>E</i>)-<i>N</i>'-Benzylidene-2-oxo-2<i>H</i>-chromene-3-carbohydrazide
C17H12N2O3
Acta Crystallographica Section E (2019) 75, 10 1403-1410
a=5.67150(10)Å b=7.41640(10)Å c=15.9819(3)Å
α=88.3690(10)° β=84.1470(10)° γ=82.961(2)°